Same-day Topamax appointment in Illinois

If you’re struggling with Binge Eating Disorder (BED), you’re not alone—and getting help has become more accessible than ever through telehealth. But navigating the confusing landscape of online prescribing rules, state regulations, and medication options can feel overwhelming. Can you really get BED medication through a video visit? Is it legal? Is it safe?

The short answer: Yes, you can legally receive medication for Binge Eating Disorder via telehealth in every U.S. state—and the rules supporting this care are stronger than you might think.

This comprehensive guide cuts through the confusion, explaining exactly how telehealth prescribing works for BED medications like Topamax (topiramate) and Wellbutrin (bupropion), what regulations apply in 2025-2026, and what you need to know to access safe, effective virtual care.

Understanding Binge Eating Disorder and Treatment Options

Before diving into the regulations, let’s clarify what Binge Eating Disorder is and why medication might be part of your treatment plan.

What Is Binge Eating Disorder?

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of people. According to DSM-5 diagnostic criteria, BED involves:

• Recurrent episodes of binge eating characterized by consuming an unusually large amount of food within a discrete period (typically within 2 hours)
• Feeling a lack of control during these episodes—feeling like you can’t stop eating or control what or how much you’re eating
• Marked distress regarding the binge eating
• Occurring at least once a week for three months
• Not associated with compensatory behaviors like purging, excessive exercise, or fasting (which would indicate bulimia nervosa)

Additional features often include eating more rapidly than normal, eating until uncomfortably full, eating large amounts when not physically hungry, eating alone due to embarrassment, and feeling disgusted, depressed, or guilty afterward.

Why Medication for BED?

While psychotherapy (particularly cognitive-behavioral therapy and dialectical behavior therapy) remains a cornerstone of BED treatment, medication can be an important tool, especially when:

• Therapy alone hasn’t provided sufficient symptom relief
• You’re experiencing co-occurring conditions like depression or anxiety
• You need additional support while engaging in therapy
• Binge eating episodes remain frequent despite behavioral interventions

The only FDA-approved medication specifically for BED is lisdexamfetamine (Vyvanse), a controlled stimulant. However, because of strict regulations around controlled substances and telehealth (more on this later), most legitimate telehealth providers focus on effective off-label alternatives that are non-controlled medications.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Two Main Non-Controlled Medications for BED

Topamax (Topiramate)

What it is: Originally FDA-approved for seizure disorders and migraine prevention, topiramate has shown promise in treating Binge Eating Disorder through off-label use.

How it may help BED: Research suggests topiramate can help reduce binge frequency and may support weight management. It’s thought to work by affecting neurotransmitters that influence impulse control and appetite regulation.

Key considerations:

• Not FDA-approved for BED but supported by clinical research for off-label use
• Typically started at low doses (25-50 mg) and gradually increased
• Contraindicated in pregnancy—topiramate has been linked to birth defects including cleft palate. Effective contraception is essential for women of childbearing potential
• Requires gradual tapering when discontinuing to avoid seizure risk
• Common side effects include tingling sensations, cognitive effects (‘brain fog’), changes in taste, and potential weight loss
• Regular monitoring for metabolic and cognitive side effects is recommended

Wellbutrin (Bupropion)

What it is: FDA-approved for depression and smoking cessation, bupropion is increasingly used off-label for Binge Eating Disorder.

How it may help BED: Studies have shown bupropion can help reduce binge frequency in some patients. As a norepinephrine-dopamine reuptake inhibitor, it may help with impulse control and mood regulation that can contribute to binge eating.

Key considerations:

• Not FDA-approved for BED but has research support for off-label use
• Contraindicated in patients with current or past bulimia or anorexia nervosa due to significantly increased seizure risk
• Cannot be used if you have a seizure disorder or conditions that increase seizure risk
• Carries an FDA black box warning about increased suicidal thoughts in people under 25, particularly when starting treatment—close monitoring is essential
• Should not be combined with alcohol (increases seizure risk)
• May increase blood pressure—monitoring recommended, especially if taking other stimulants
• Available in immediate-release, sustained-release (SR), and extended-release (XL) formulations

Federal Telehealth Prescribing Rules: The Foundation

Understanding federal regulations is crucial because they set the baseline for what’s possible nationwide.

The Ryan Haight Act and Why It Doesn’t Apply Here

The Ryan Haight Act (2008) is a federal law that requires an in-person medical evaluation before prescribing controlled substances via telemedicine. This law was designed to prevent online ‘pill mills’ from distributing addictive medications without proper oversight.

Here’s the critical point: The Ryan Haight Act only applies to controlled substances (Schedule II-V drugs regulated by the DEA). Topamax and Wellbutrin are not controlled substances—they’re ‘legend drugs’ (prescription medications) but not DEA-scheduled.

This means there has never been a federal requirement for an in-person visit before prescribing these BED medications via telehealth. The confusion often arises because people conflate rules about controlled substances (like Adderall or Vyvanse) with all prescription medications.

Current DEA Telehealth Flexibilities (For Controlled Substances)

While not directly relevant to Topamax and Wellbutrin, it’s worth understanding the current landscape:

During the COVID-19 public health emergency, the DEA waived the Ryan Haight Act’s in-person requirement for controlled substances. This flexibility has been extended through December 31, 2026 while the DEA works on permanent rules. This fourth extension was announced in January 2026.

However, these temporary rules and their potential expiration do not affect non-controlled medications. Your access to BED medications like topiramate and bupropion via telehealth remains unaffected by DEA controlled substance policies.

What This Means for You

You can receive prescriptions for Topamax or Wellbutrin through telehealth without ever having an in-person visit at the federal level. The provider must:

• Be licensed in your state
• Conduct an appropriate evaluation (which can be done entirely via telehealth)
• Follow standard medical care guidelines
• Maintain proper documentation

State-by-State Telehealth Prescribing: What You Need to Know

While federal law sets the baseline, states can impose additional requirements. The good news: most states have permanently adopted telehealth-friendly policies following the pandemic.

The General Rule: No In-Person Requirement

In most states, there is no mandatory in-person visit before receiving non-controlled medications via telehealth. The pandemic accelerated a shift that made telehealth evaluations equivalent to in-person exams for prescribing purposes.

States like California, New York, Texas, Florida, and many others explicitly allow telehealth prescribing of non-controlled medications without an in-person requirement, as long as the standard of care is met.

States with Periodic In-Person Requirements

A handful of states require periodic in-person visits for ongoing telehealth treatment:

Alabama: If you receive more than 4 telehealth visits in 12 months for the same condition, an in-person exam is required within that year. However, this can be satisfied by seeing any healthcare provider in person (including a collaborating provider), not necessarily your telehealth prescriber.

Georgia: Providers must attempt to see patients in person at least annually for ongoing telemedicine care. Initial evaluation can be via telehealth if it’s equivalent to an in-person exam.

New Hampshire: For medications including some controlled substances, an in-person follow-up is required within 12 months. While this technically applies more to controlled meds, it’s worth knowing if you’re in NH.

These periodic requirements are designed to ensure continuity of care and aren’t typically barriers to starting treatment via telehealth—they just mean you’ll need to plan for an eventual in-person check-in.

Recent State Law Updates (2025-2026)

Several states have modernized their telehealth laws recently:

California (AB 1503, 2025): Redefined ‘good faith examination’ to explicitly include asynchronous telehealth (like online questionnaires combined with provider review), expanding prescribing flexibility.

Delaware (SB 101, July 2025): Clarified that telemedicine is allowed for medication-assisted treatment of opioid use disorder, resolving previous conflicts—though this doesn’t directly affect BED meds, it shows the state’s commitment to telehealth access.

New Hampshire (SB 252, August 2025): Explicitly allowed telehealth prescribing of Schedule II-IV controlled substances without initial in-person visit (with annual follow-up required), modernizing their telehealth framework.

New York (Final Rule, May 2025): Adopted new rules requiring in-person exams for controlled substance prescribing (with exceptions), but explicitly exempted non-controlled medications—telehealth prescribing of Topamax and Wellbutrin remains fully accessible.

Wisconsin (APRN Modernization Act, August 2025): Granted nurse practitioners full practice authority, expanding who can prescribe via telehealth.

Michigan (Public Act 47 of 2023, implemented 2025): Joined full practice authority states, allowing NPs to practice independently.

Who Can Prescribe: Understanding Provider Types

All states allow physicians (MDs and DOs) to prescribe BED medications via telehealth. But what about Nurse Practitioners (NPs) and Physician Assistants (PAs)?

Full Practice Authority States (34 states + DC): In these states, NPs can evaluate, diagnose, and prescribe medications independently without physician oversight. Examples include California, New York, Connecticut, Colorado, Maryland, and recently Wisconsin and Michigan. If you’re seeing an NP via telehealth in these states, they can prescribe Topamax or Wellbutrin entirely on their own.

Collaborative/Reduced Practice States: In states like Texas, Florida, Alabama, and Georgia, NPs and PAs must work under a collaborative agreement with a physician. This doesn’t typically affect your care—the NP can still prescribe your medication, but there’s a supervising physician in the background who may co-sign or oversee the prescription. You might see both names on your prescription.

What matters for you: Whether your provider is an MD, DO, NP, or PA, they can legally prescribe non-controlled BED medications via telehealth in all 50 states, though the level of supervision varies by state.

How Telehealth Prescribing Actually Works

The Initial Evaluation

A legitimate telehealth evaluation for BED should be thorough—expect 30-45 minutes for an initial consultation. Your provider will:

1. Verify your identity and location (required by many state laws)
2. Conduct a detailed clinical interview about your eating behaviors, including:

• Frequency and nature of binge episodes
• Triggers and patterns
• Emotional state during and after binges
• Previous treatment attempts
• Co-occurring mental health conditions

1. Review your medical history, including:

• Current medications
• Past medical conditions
• Pregnancy status or plans
• History of seizures, eating disorders, or other contraindications

1. Screen for contraindications to specific medications
2. Discuss treatment options, including therapy, lifestyle interventions, and medication
3. Obtain informed consent for telehealth treatment and off-label medication use
4. Develop a treatment plan with clear goals and follow-up schedule

Documentation and Diagnosis

Your provider will document that you meet DSM-5 criteria for Binge Eating Disorder, which requires evidence of:

• Recurrent binge eating episodes
• Lack of control during episodes
• Marked distress
• At least weekly frequency for three months
• Absence of compensatory behaviors

This documentation goes into a secure electronic health record and supports the medical necessity of treatment.

Prescription Monitoring Programs (PMPs)

Many states require prescribers to check the state’s Prescription Monitoring Program database before prescribing controlled substances. Since Topamax and Wellbutrin are not controlled substances, these mandatory checks typically don’t apply.

However, good providers may still review your medication history as part of due diligence—for example, to ensure you’re not already on another bupropion prescription or to check for potential drug interactions. This is clinical best practice, not a legal requirement for non-controlled meds.

Getting Your Prescription

After evaluation, your provider will send your prescription electronically to a pharmacy of your choice. You can typically:

• Pick it up at a local pharmacy
• Use a mail-order pharmacy (if the provider is licensed in your state)
• Transfer it to another pharmacy if needed

Red flag: Be wary of any telehealth service that wants to sell you medication directly without using a licensed pharmacy. Legitimate services use standard pharmacy channels for medication dispensing.

Follow-Up Care

Even though these are non-controlled medications, expect regular follow-up:

Initial phase (first 1-3 months):

• Check-in at 2 weeks to assess tolerance and side effects
• Monthly visits to monitor response and adjust dosage
• More frequent contact if you experience concerning symptoms

Maintenance phase:

• Visits every 1-3 months depending on stability
• Some states require at least annual contact
• Ongoing assessment of binge frequency, side effects, and overall progress

Refills: Since these aren’t controlled substances, providers can typically authorize refills for up to 6-12 months (depending on state regulations), though you’ll still need regular follow-up appointments.

Safety Considerations: Who Should and Shouldn’t Use Telehealth for BED

Good Candidates for Telehealth BED Treatment

You may be well-suited for telehealth if you:

• Meet DSM-5 criteria for Binge Eating Disorder
• Have stable physical health without urgent medical concerns
• Can participate in video visits (have necessary technology)
• Live in an area where the provider is licensed
• Are willing to engage in regular follow-up
• Don’t have contraindications to the proposed medication
• Understand and consent to off-label medication use
• Are willing to combine medication with therapy or other interventions

Who May Not Be Appropriate for Telehealth

Telehealth providers will screen out patients who:

Have medication contraindications:

• History of bulimia or anorexia nervosa (for Wellbutrin—significant contraindication due to seizure risk)
• Current or past seizure disorder (for Wellbutrin; topiramate used with extreme caution)
• Pregnant or planning pregnancy (topiramate linked to birth defects)
• Uncontrolled narrow-angle glaucoma (topiramate)

Have complex medical needs:

• Severe obesity with urgent complications requiring in-person evaluation
• Uncontrolled chronic conditions (diabetes, hypertension) needing coordination
• Recent hospitalizations or medical instability
• Neurological symptoms needing physical examination

Need controlled substances:

• If evaluation suggests you truly need Vyvanse (the FDA-approved BED medication, which is a controlled stimulant), you may be referred for in-person care due to stricter controlled substance regulations

Have active safety concerns:

• Acute suicidal ideation (especially relevant given Wellbutrin’s black box warning)
• Active substance use disorder that requires more intensive monitoring
• Inability to consent or participate in telehealth visits

Understanding Off-Label Use

It’s important to understand that both Topamax and Wellbutrin are prescribed off-label for Binge Eating Disorder. Off-label prescribing means using an FDA-approved medication for a condition it wasn’t specifically approved to treat.

This is completely legal and very common in medicine. In fact, off-label prescribing accounts for a significant portion of psychiatric and weight management treatments. The key is that:

• There’s clinical research supporting the use
• The provider explains risks and benefits
• You give informed consent
• The decision is documented in your medical record

Reputable providers will be transparent about off-label use and discuss why they’re recommending a particular medication over others.

Quality and Safety in Telehealth: What to Look For

The telehealth industry has matured significantly since the pandemic, but not all services are created equal. Here’s how to identify high-quality care:

Signs of a Legitimate Service

Thorough evaluation process:

• Initial visit lasts 30+ minutes
• Detailed questions about symptoms, history, and lifestyle
• Discussion of non-medication options
• Clear explanation of medication risks and benefits
• No pressure to choose medication

Proper credentialing:

• Providers licensed in your state
• Credentials clearly displayed
• Board certification in psychiatry, family medicine, or related specialty preferred
• Clear information about who will be treating you

Appropriate scope:

• Clearly states what they will and won’t prescribe
• Doesn’t promise prescriptions before evaluation
• Refers out when appropriate (e.g., for controlled substances, complex cases)
• Emphasizes medication as part of comprehensive treatment

Safety protocols:

• Verifies your identity and location
• Checks for drug interactions
• May review prescription monitoring databases
• Provides clear emergency contact information
• Has protocols for after-hours concerns

Transparent practices:

• Clear pricing (discussed below)
• Detailed informed consent process
• Privacy practices compliant with HIPAA
• Real humans available for questions

Red Flags to Avoid

Beware of services that:

• Promise prescriptions before proper evaluation
• Rush through appointments (5-10 minute ‘consultations’)
• Don’t ask about medical history or contraindications
• Sell medication directly rather than using licensed pharmacies
• Focus solely on medication without discussing therapy
• Have unclear provider credentials or licensing
• Use high-pressure sales tactics
• Make unrealistic promises about results
• Don’t provide clear contact information for follow-up

The 2024 case of a telehealth startup whose executives were indicted for unsafe ADHD medication prescribing serves as a cautionary tale. Legitimate providers have responded by implementing stricter protocols, and regulatory oversight has increased. Choose services with established reputations and clear safety standards.

Cost and Insurance Considerations

Typical Costs

Evaluation visit: $150-$300 for initial consultationFollow-up visits: $75-$150 per visitMedication costs:

• Topamax (topiramate): $10-$50/month generic
• Wellbutrin (bupropion): $10-$40/month generic

Insurance Coverage

Many insurance plans now cover telehealth at parity with in-person visits. Coverage typically includes:

• The virtual visit itself
• Prescription medications (subject to formulary)

However, coverage varies by:

• Your specific insurance plan
• Whether the provider is in-network
• Your state’s telehealth parity laws
• The diagnosis code used (BED vs. depression, for example)

Important: Some insurance plans may more readily cover these medications when prescribed for their FDA-approved indications (depression for Wellbutrin, seizures/migraines for Topamax) rather than for BED. Your provider can work with you on diagnosis coding that’s both accurate and optimizes coverage.

Cash-Pay Options

Many telehealth platforms offer cash-pay options if you:

• Don’t have insurance
• Have high deductibles
• Prefer not to use insurance for privacy reasons
• See an out-of-network provider

Platforms like Klarity Health offer transparent pricing for both insured and cash-pay patients, with straightforward fee structures and no surprise costs. They accept both insurance and self-pay, providing flexibility based on your financial situation.

Financial Assistance

Some options if cost is a concern:

• Generic versions of medications (significantly cheaper)
• Prescription discount programs (GoodRx, RxSaver)
• Manufacturer patient assistance programs
• Community mental health centers offering sliding-scale telehealth
• Employee assistance programs (EAPs) that may cover initial visits

Finding the Right Telehealth Provider

What to Look For in a Platform

Comprehensive care approach:

• Offers both medication management and therapy
• Care coordination between providers
• Integration with in-person care if needed
• Nutritional counseling or referrals

Provider availability:

• Reasonable appointment wait times
• Accessible follow-up scheduling
• Clear protocols for urgent concerns
• Consistent care with the same provider when possible

Technology that works:

• User-friendly video platform
• Secure messaging for non-urgent questions
• Easy prescription management
• Mobile app option

Evidence-based approach:

• Providers trained in eating disorders
• Use of validated screening tools
• Measurement-based care (tracking symptoms over time)
• Incorporation of clinical guidelines

Questions to Ask Before Starting

Before committing to a telehealth service, ask:

1. ‘What is your approach to treating Binge Eating Disorder?’
2. ‘What are your prescribing policies for BED medications?’
3. ‘How do you coordinate with my other providers?’
4. ‘What happens if I need in-person care?’
5. ‘What are your follow-up protocols?’
6. ‘How do I reach someone if I have concerns between appointments?’
7. ‘What are the total costs, and what does my insurance cover?’
8. ‘Who will I be seeing—the same provider each time?’

Klarity Health: Accessible, Transparent BED Treatment

If you’re looking for a telehealth option that combines clinical expertise with patient-centered care, Klarity Health offers several advantages:

Provider availability: Klarity maintains a network of licensed psychiatrists and psychiatric nurse practitioners across multiple states, with appointment availability often within days rather than weeks—crucial when you’re ready to start treatment.

Transparent pricing: No hidden fees or surprise charges. Klarity clearly outlines costs for both insurance and cash-pay patients upfront, so you know exactly what you’ll pay before your first appointment.

Flexible payment options: Whether you have insurance or prefer to pay out-of-pocket, Klarity accepts both, making quality mental health care more accessible regardless of your insurance status.

Comprehensive approach: Klarity providers understand that medication is just one tool in treating BED. They can help coordinate your care, discuss therapy options, and create a holistic treatment plan tailored to your needs.

Looking Ahead: The Future of Telehealth for BED

Regulatory Stability

The telehealth landscape has stabilized significantly since the pandemic’s early days. While controlled substance rules remain in flux (with the current extension lasting through December 31, 2026), non-controlled medication prescribing via telehealth is here to stay.

Most states have made temporary pandemic-era flexibilities permanent, recognizing that telehealth expands access without compromising safety when proper standards are followed.

What to Monitor

DEA’s final rule on controlled substances: Expected by late 2026, this will clarify permanent rules for prescribing controlled meds (like Vyvanse) via telehealth. While this doesn’t affect Topamax or Wellbutrin, it may expand your future treatment options.

State scope of practice changes: More states are moving toward full practice authority for nurse practitioners, which could increase provider availability in your area. Alabama and South Carolina have pending legislation that may expand NP independence.

Temporary waivers: If you’re in a state with temporary telehealth flexibilities, monitor expiration dates (though most permanent changes are unlikely to be rolled back given their success).

Emerging Opportunities

Integration with digital therapeutics: Apps and digital programs for BED are increasingly being integrated with telehealth medication management, offering a more comprehensive treatment approach.

Improved access in rural areas: Telehealth is particularly valuable for patients in underserved areas where eating disorder specialists are scarce.

Reduced stigma: The privacy of telehealth can reduce barriers for people who feel embarrassed seeking treatment for eating disorders.

Taking the First Step

If you’re struggling with Binge Eating Disorder, know that effective, accessible treatment is available through telehealth. Here’s how to start:

1. Recognize that you deserve help. BED is a legitimate medical condition that responds to treatment—you don’t have to manage it alone.

2. Research telehealth providers in your state. Look for services with specialized eating disorder expertise, transparent practices, and good reputations.

3. Prepare for your evaluation. Track your binge eating episodes for a week or two before your appointment: how often, what triggers them, how you feel afterward. This information helps your provider understand your experience.

4. Be honest and thorough. Telehealth only works when providers have complete information. Discuss all symptoms, medications, and concerns openly.

5. Ask questions. Don’t leave your appointment unclear about your diagnosis, treatment plan, medication risks, or follow-up schedule.

6. Combine approaches. Medication can be very helpful, but it typically works best alongside therapy, nutritional counseling, and lifestyle changes. Be open to a comprehensive approach.

7. Give it time. Both medications discussed typically take several weeks to show benefits. Work with your provider to find the right dosage and approach.

8. Stay connected. Don’t skip follow-up appointments. Regular monitoring ensures safety and allows for treatment adjustments.

Conclusion

Telehealth has fundamentally transformed access to eating disorder treatment, making specialized care available to people regardless of where they live. The regulatory framework supporting telehealth prescribing of non-controlled medications like Topamax and Wellbutrin for Binge Eating Disorder is robust and stable.

You can confidently pursue telehealth treatment knowing that:

• It’s fully legal in all 50 states
• Safety standards are strong and getting stronger
• Providers can prescribe effective medications without in-person visits in most cases
• Quality services exist that prioritize your health over profit
• You have options whether you use insurance or pay out-of-pocket

Binge Eating Disorder doesn’t have to control your life. With the right support—which may include medication, therapy, and other interventions—recovery is absolutely possible. Telehealth removes barriers that once kept people from getting help, making it easier than ever to take that crucial first step.

Ready to explore your options? Consider reaching out to a telehealth provider today to discuss whether medication-assisted treatment for BED might be right for you.

Research Currency Statement

Verified as of: January 4, 2026

Federal Status:

• DEA telehealth prescribing flexibilities for controlled substances remain in effect through December 31, 2026 (fourth extension). Non-controlled medications (including BED medications discussed) were never subject to Ryan Haight Act restrictions and require no special in-person requirements federally.

State Verification:

• Information reflects latest state laws and regulations as of late 2025, with 10+ key states researched in detail (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, SC).
• 80%+ of sources are from 2025 or updated to reflect 2025 status.

Flagged for Follow-up:

• Alabama and South Carolina NP scope legislation (discussed in 2025 but final status requires confirmation)
• DEA’s pending final rule on telehealth prescribing (expected by end of 2026)
• Temporary state waivers should be verified for any extensions beyond stated dates

Citations

1. U.S. Department of Health and Human Services. (2026). DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Health Law Blog. (2025). Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions. Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. (2025). State Telehealth Laws and Reimbursement Policies: Online Prescribing. Retrieved from https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide Blog. (2025). State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025). Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. DailyMed, National Institutes of Health. (2024). Bupropion Hydrochloride Extended-Release Tablets Label. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12